The analysis by property advisory firm Knight Frank found a 22% increase in the number of life science companies domiciled in the UK between 2019 and the end of 2025, to a total of 15,436.

Josh is the Global Real Estate transaction lead for GSK, focusing on aligning real estate strategies with business objectives and transforming the portfolio to create the World’s healthiest workplaces ...

New Flagship Pioneering biotech Quotient Therapeutics has lots to be thankful for this year, namely $50 million in cash, a new U.K. outpost to work from and a formal unveiling as the holiday season ...

-Second Quarter 2024 revenues are expected to fall between $15.5-$16.0 million, reflecting double digit percentage year over year growth- -Reiterating financial guidance of approximately $20 million ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

The U.K. government has pledged that a chunk of the 650 million pound sterling ($803 million) funding package it has earmarked to boost the country’s life sciences industry will go toward reversing ...

The new year brought a slew of new faces in the pharma and biotech world, especially in the top jobs, with a number of CEO changes at biotech firms. Read on for the first Changing Faces of 2026.

LONDON (Reuters) - A top biotech and healthcare investor is calling for the launch of two government-backed funds worth a combined 1 billion pounds ($1.78 billion) to help finance the battered sector.

LONDON Jan 22 (Reuters) - The British government should offer tax incentives for the pharmaceutical industry to invest in biotechnology, a report produced under the umbrella of the UK's BioIndustry ...